Having trouble accessing articles? Reset your cache.

Oct. 18 Company Quick Takes: AZ-Daiichi, Sanofi, Merck, Lilly and AFTD-Target ALS

Priority Review for breast cancer ADC from Daiichi, AZ
AstraZeneca plc (LSE:AZN; NYSE:AZN) and Daiichi Sankyo Co. Ltd. (Tokyo:4568) said FDA accepted and granted Priority Review to a BLA

Read the full 289 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE